COR · NYSE · Health Care Distributors
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Sep 16, 2026 · Filed Sep 17, 2026
Director sold ~$411K of COR shares in the open marketSourcePlanned sale · Planned for Sep 16, 2026 · Notice filed Sep 16, 2026
Director filed to sell about $411K of COR stockSourcePlanned sale · Planned for Sep 11, 2026 · Notice filed Sep 11, 2026
Officer filed to sell about $430K of COR stockSourcePlanned sale · Planned for Sep 4, 2026 · Notice filed Sep 4, 2026
Officer filed to sell about $3.35M of COR stockSourceInsider trade · Traded Sep 1, 2026 · Filed Sep 3, 2026
Officer sold ~$321K of COR shares in the open marketSourceInsider trade · Traded Aug 24, 2026 · Filed Aug 26, 2026
Officer sold ~$3.66M of COR shares in the open marketSourceFund holdings · Holdings as of Jun 30, 2026 (Q2 2026) · Filed Aug 14, 2026
Bridgewater Associates disclosed an increased position in COR for Q2 2026SourceCongress trade · Transaction Mar 27, 2026 · Disclosed Jul 21, 2026
Disclosed purchase of COR — reported range $1,001 - $15,000SourceInsider trade · Traded Jun 22, 2026 · Filed Jun 25, 2026
Director purchased ~$149K of COR shares in the open marketSourceInsider trade · Traded Jun 18, 2026 · Filed Jun 23, 2026
Director purchased ~$1.1M of COR shares in the open marketSourceCongress trade · Transaction May 6, 2026 · Disclosed Jun 19, 2026
Disclosed sale of COR — reported range $1,001 - $15,000SourceCongress trade · Transaction May 6, 2026 · Disclosed Jun 19, 2026
Disclosed sale of COR — reported range $1,001 - $15,000SourceInsider trade · Traded May 28, 2026 · Filed May 29, 2026
Director purchased ~$1.07M of COR shares in the open marketSourceCongress trade · Transaction Mar 31, 2026 · Disclosed Apr 30, 2026
Disclosed purchase of COR — reported range $1,001 - $15,000SourceCongress trade · Transaction Mar 23, 2026 · Disclosed Apr 30, 2026
Disclosed purchase of COR — reported range $1,001 - $15,000SourceCongress trade · Transaction Mar 23, 2026 · Disclosed Apr 30, 2026
Disclosed purchase of COR — reported range $1,001 - $15,000SourceInsider trade · Traded Feb 20, 2026 · Filed Feb 25, 2026
CEO sold ~$1.35M of COR shares in the open marketSourceInsider trade · Traded Feb 18, 2026 · Filed Feb 21, 2026
CEO sold ~$479K of COR shares in the open marketSourceInsider trade · Traded Jan 20, 2026 · Filed Jan 23, 2026
CEO sold ~$1.81M of COR shares in the open marketSourceInsider trade · Traded Dec 18, 2025 · Filed Dec 23, 2025
CEO sold ~$1.75M of COR shares in the open marketSourceInsider trade · Traded Dec 19, 2025 · Filed Dec 23, 2025
Officer sold ~$1.15M of COR shares in the open marketSourceInsider trade · Traded Dec 19, 2025 · Filed Dec 23, 2025
Officer sold ~$579K of COR shares in the open marketSourceInsider trade · Traded Dec 17, 2025 · Filed Dec 20, 2025
Officer sold ~$1.38M of COR shares in the open marketSourceInsider trade · Traded Nov 18, 2025 · Filed Nov 20, 2025
CEO sold ~$1.87M of COR shares in the open marketSourceInsider trade · Traded Oct 20, 2025 · Filed Oct 22, 2025
CEO sold ~$1.67M of COR shares in the open marketSourceInsider trade · Traded Oct 1, 2025 · Filed Oct 4, 2025
Officer sold ~$591K of COR shares in the open marketSourceCongress trade · Transaction May 12, 2025 · Disclosed Jun 22, 2025
Disclosed sale of COR — reported range $50,001 - $100,000SourceCongress trade · Transaction Mar 27, 2025 · Disclosed Apr 8, 2025
Disclosed sale of COR — reported range $15,001 - $50,000Source